Fecal Microbiota Transplantation for Pancreatitis With Infectious Complications(FMTPIC)
NCT02318147 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2017-10-18
Summary
Infectious complications are responsible for most of deaths in acute pancreatitis.Intestinal barrier dysfunction and increased intestinal permeability was associated with bacterial translocation which is believed to prompted these infections.The purpose of this clinical trail is to observe the potential capability of FMT in reduce the bacterial translocation and alleviate infectious complications by the reconstruction of a gut functional state.
Conditions
- Acute Pancreatitis
- Fecal Microbiota Transplantation
- Bacterial Translocation
- Infectious Complications
Interventions
- PROCEDURE
-
Fecal Microbiota Transplantation
FMT by retention enema with fresh bacteria from healthy donor
- DRUG
-
The traditional treatment
the traditional treatments according to associated guidelines
Sponsors & Collaborators
-
The First Affiliated Hospital of Nanchang University
lead OTHER
Principal Investigators
-
Nonghua Lv, MD · the Frist Affiliated Hospital of Nanchang University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
Countries
- China
Study Locations
More Related Trials
-
Gastrointestinal Microflora and Serum Metabolomics in Patients With Pancreatic Cancer and Chronic Pancreatitis
NCT06411470 ·Status: RECRUITING
-
Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases
NCT05193162 ·Status: RECRUITING
-
Intermittent Fasting for Pancreatitis
NCT04760847 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Combined Stent Insertion and HIFU Ablation for Pancreatic Carcinoma With Biliary Obstruction
NCT03962478 ·Status: COMPLETED ·Phase: NA
-
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
NCT07217717 ·Status: RECRUITING ·Phase: PHASE3
-
Follow-up Study of Complications of Acute Pancreatitis
NCT02305914 ·Status: UNKNOWN
-
Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
NCT06663072 ·Status: RECRUITING ·Phase: PHASE1
-
Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer
NCT00547612 ·Status: COMPLETED ·Phase: PHASE1
-
Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx
NCT00767273 ·Status: COMPLETED ·Phase: NA
-
Intestinal Microbiota Composition in Patients With Chronic Pancreatitis and Pancreatic Exocrine Insufficiency
NCT05132309 ·Status: COMPLETED
-
Pancreatitis - Microbiome as Predictor of Severity II
NCT06508502 ·Status: RECRUITING
-
Microbiome Characterization in Fatty Pancreas
NCT06938646 ·Status: ACTIVE_NOT_RECRUITING
-
Exploring the Mechanism of Severe Acute Pancreatitis Based on Metagenomics, Metabolomics and Proteomics
NCT06230432 ·Status: NOT_YET_RECRUITING
-
Stereotactic Radiation to Decrease Pancreatic Secretions
NCT01656486 ·Status: COMPLETED ·Phase: NA
-
Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry
NCT03724435 ·Status: TERMINATED
-
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died
NCT00061438 ·Status: COMPLETED ·Phase: PHASE4
-
A Novel Surgical Strategy to Reduce Major Complications in Patients With Necrotizing Pancreatitis
NCT06241586 ·Status: COMPLETED
-
BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer
NCT01571024 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer
NCT04324307 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Microbial Diversity of Pancreatic Diseases
NCT03809247 ·Status: RECRUITING
-
First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI
NCT03693677 ·Status: COMPLETED ·Phase: PHASE2
-
Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer
NCT05201729 ·Status: UNKNOWN
-
Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
NCT01017822 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic Cancer
NCT03469375 ·Status: COMPLETED
-
Intra-arterial Versus Intravenous Chemotherapy for Locally Advanced Pancreatic Cancer
NCT02635971 ·Status: UNKNOWN ·Phase: PHASE2